Results 161 to 170 of about 12,992 (201)

Correction to: Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases. [PDF]

Int J Retina Vitreous
Jorge R, Rego MGB, Zupelli AS, Calado RT.   +3 more
europepmc   +1 more source

Ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria during pregnancy. [PDF]

Blood Adv
Höchsmann B, Gerber GF, Leopold W, Patel BJ, Gavriilaki E, Hefter A, Kalhammer U, Opitz S, Marx-Hoffmann A, Knight DB, Brodsky RA, Marvaki A, Lalayanni C, Körper S, Babushok DV, Schrezenmeier H.   +15 more
europepmc   +1 more source

Measurement of complement proteins may aid interpretation of pathophysiology in kidney transplant recipients with atypical hemolytic uremic syndrome. [PDF]

CEN Case Rep
Miura M, Higashiyama H, Tsuji T, Ohtani K, Wakamiya N.   +4 more
europepmc   +1 more source

Severe Class III Lupus Nephritis With Concurrent Thrombotic Microangiopathy and Suspected Atypical Hemolytic Uremic Syndrome Requiring Complement Blockade: A Complex Multisystem Presentation. [PDF]

Cureus
Pokharel N, Alvi A, Best A.
europepmc   +1 more source

Aquaporin-4's dynamic expression and biological variations within the tumor obscure the paraneoplastic phenomenon in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder. [PDF]

Acta Neuropathol
Kothapalli NP, Guo Y, Vorasoot N, Wingerchuk DM, Flanagan EP, Dubey D, Tisavipat N, Cuascut FX, Patel HY, Lucchinetti CF, Pittock SJ.   +10 more
europepmc   +1 more source

Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases. [PDF]

Int J Retina Vitreous
Jorge R, Rego MGB, Zupelli AS, Calado RT.   +3 more
europepmc   +1 more source

Case Report: Short-course defibrotide combined with eculizumab for TA-TMA. [PDF]

Front Immunol
Yan Y, Li X, Li L, Zhang S, Ma L, Huang L, Tian W, Zhao J.   +7 more
europepmc   +1 more source

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107. [PDF]

Blood Adv
europepmc   +1 more source

Eculizumab☆

, 2010
In deep review on eculizumab pharmacology and ...
CATALDI, MAURO, A. Cavaccini
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Eculizumab

Reactions Weekly
  +11 more sources